Message sent

Thank you for reaching out. We aim to respond within 2 business days.

Back to home

Engineering platelets into targeted medicines via the Platelet Transfer Technology (PTT).

HQ — Perugia

Via San Damiano 14 06121 Perugia PG, Italy

R&D — Caserta

Neurobiotech – Polo d'Innovazione Tecnologica Viale T. A. Edison, 81100 Caserta CE, Italy

Science

Platform (PTT)
Pipeline
Regenerative — PLA-REGEN
Oncology — PLA-ONCO
Publications

Company

About Plasfer
Investors & Partners
Careers
News
Contact

Get in touch

info@plasfer.bio
LinkedIn

Partner with us

Regulatory disclaimer: The information on this website is for general informational purposes only and does not constitute medical advice, investment advice, or an offer to buy or sell any security. All product candidates and programmes are investigational, not approved for any indication by any regulatory authority. PLA-REGEN is intended to pursue a medical-device / human platelet lysate (hPL) regulatory route and is not yet CE-marked. No claims of safety, efficacy, or regulatory approval are made or implied. This website may contain forward-looking statements; actual results may differ materially from those anticipated.

Privacy Policy
Cookie Policy

We use essential cookies to make this site work. Optional analytics cookies are disabled by default. Read our Cookie Policy and Privacy Policy.